Quick Answer
CLOVER HEALTH INVESTMENTS, CORP. /DE reported Total Revenue of $1.92 billion for the year ending 2025.
- CLOVER HEALTH INVESTMENTS, CORP. /DE showed an increase of +40.3% in Total Revenue from 2024 to 2025.
- This data is from CLOVER HEALTH INVESTMENTS, CORP. /DE's annual report (Form 10-K), filed with the SEC on February 27, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2020: $165.51 million | Q2 2020: $172.08 million | Q3 2020: $169.07 million | Q1 2021: $200.33 million | Q2 2021: $412.47 million | Q3 2021: $427.16 million | Q1 2022: $874.38 million | Q2 2022: $846.70 million | Q3 2022: $856.82 million | Q1 2023: $321.99 million | Q2 2023: $320.14 million | Q3 2023: $306.03 million | Q1 2024: $346.92 million | Q2 2024: $356.26 million | Q3 2024: $330.99 million | Q1 2025: $462.33 million | Q2 2025: $477.62 million | Q3 2025: $496.65 million.
- Over the full 7 years of available data (2019 to 2025), CLOVER HEALTH INVESTMENTS, CORP. /DE's Total Revenue has grown by 316.3%.
- Historical annual values: Fiscal year 2025: $1.92 billion | Fiscal year 2024: $1.37 billion | Fiscal year 2023: $1.26 billion | Fiscal year 2022: $1.10 billion | Fiscal year 2021: $1.47 billion | Fiscal year 2020: $672.89 million | Fiscal year 2019: $462.27 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: